Jakarta –BRIN Public Relations. Transfer of equipment from the laboratory of the Eijkman Building is part of the restructuring of research and facilities at Eijkman. To ensure that all goods are in accordance with their latest status, the team must carry out a stock taking process of all goods and equipment prior to the handing over. “We certainly do not want any equipment to be damaged. All of these will be managed as part of resource sharing for all researchers by following the existing SOP (standard operational procedure),”said Head of the National Research and Innovation Agency (BRIN), Lakasan Tri Handoko, Sunday (13/2).

“Information about the transfer of equipment not in line with the procedure is not true,” he asserted. The relocated tools/machines are not of NovaSeq6000, but are sanger sequencing machine. The infrastructure team has consulted with the vendor and they have agreed on the procedure. After relocation, the Sanger ABI 3500XL sequencing machine will be installed, tested for function and recalibrated by the vendor namely PT. Enigma.

Meanwhile, relocation of the Novaseq Illumina machine and others has not yet been carried out. He explained that this was due to several reasons, particularly related to the offered price for transfer which is deemed too high, and still needs renegotiation.

Handoko continued that Eijkman lab transfer plan has been proposed by Eijkman since 2020. The main reason is that the building is too small and packed and impossible for redevelopment as it is a cultural heritage.

The option for new location of Eijkman Lab is Puspiptek or CSC (Cibinong Science Center) in Cibinong. As Eijkman was under direct administration of the Ministry of Research and Technology, it was decided that the lab was to be relocated to Puspiptek Serpong which was also under the Ministry of Research and Technology, while CSC was under LIPI. The proposed relocation fund is 1.5 trillion originating from offshore loans through JICA.

“After BRIN integration, it was decided to relocate to CSC which has indeed a research center for life sciences. Here, there are already many infrastructures available, including the newly built Genomic Building,” he added.

“At CSC, there are about 700 researchers in relevant fields, so we do not need to build from scratch that has the potential to overlap. This is one of real advantages of BRIN integration,” he revealed.

The Eijkman Building, under the agreement, has to be returned to the Ministry of Health. The building is maintained as a cultural heritage. And some of them remain as research laboratories, especially health service-based research. Meanwhile, pure laboratory-based research is centered at the new Genomic Building in Cibinong.

There are several laboratories and tools that do not need to be moved, such as BSL-3, organic TEM, forensics, and others. All laboratories and equipment are still managed by BRIN’s Deputy for Infrastructure, and are shared.

“The relocated equipment does not include those that require special treatment like NovaSec. The team has also coordinated with the vendor, and when re-installed in Cibinong, it will be recalibrated by the vendor,” he said.

Handoko is certain that the team of BRIN’s Deputy for Infrastructure has experience in conducting – maintaining – operating research equipment, ranging from vessels, aircraft to various electron microscopes. The team has also carried out an inventory and mitigation of each type of tool in Eijkman since last year.

In the new management process, all research infrastructures are managed centrally by the Deputy for Infrastructure, so that the researchers can focus on research and are not burdened by other things outside research. On the other hand, this is to ensure that all tools can be used as joint resources, hence utilization increases and facilitates all parties including campuses and industries, under certainly certain SOPs. This open platform management has been implemented since 2018 at LIPI. Hence the team handling relocation of laboratory equipment is certainly very experienced.

BRIN and RSCM have also agreed to collaborate under the BRIN Research Collaboration Center (PKR) scheme. More detailed information on the PKR scheme can be found at http://pendanaan-risnov.brin.go.id.

“There will possibly be several PKR BRIN-RSCM, among others for Genetic Forensics, and others. Thus, BRIN can still support them in the form of financing and infrastructure, although the building is managed by RSCM,” he said. “On the other hand, this will help increase the dynamics of health service-based research, because RSCM has experience in conducting clinical studies, and patient samples are available continuously,” he concluded.